Certara Expands Biosimulation Market with AI-Driven QSP Platform
Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, announced the launch of Certara IQ, a scalable, AI-powered Quantitative Systems Pharmacology (QSP) solution.
QSP has become a cornerstone of modern drug discovery and development, with QSP-based FDA submissions nearly doubling every 1.4 years since 2013.
- Combines computational modeling and experimental data to examine how a drug interacts with biological systems and disease processes.
- Enables scientists to predict critical outcomes such as optimal dosing, therapeutic window, and ideal patient populations.
“Certara IQ represents the next step in making biosimulation a foundational capability across the entire drug discovery and development value chain,”
said William F.
Author's summary: Certara launches AI-powered QSP platform.
More News
- Bose headphones and earbuds return to all-time lows for Black Friday
- Gradam RTÉ Raidió na Gaeltachta 2025 to be presented to Mayo native - news - Western People
- Nita Ambani Turns Audrey Hepburn For Halloween, Opts For Fringes, Backless Gown With Pearl Neckalce
- Adobe’s experimental AI tool can edit entire videos using one frame
- Brendan Keaney on the dance sector's future strategy
- 'Love Island's' Huda Mustafa Apologizes After Laughing At Racist Slur Hurled Towards Olandria Carthen
- Why Ryan Rollins loved Draymond Green coming for him after Stephen Curry incident
- 0-12? Stephen Curry Drops Truth Bomb On Steve Kerr's Declaration After Losing To Bucks Without Giannis
- No Giannis, No Problem — Bucks Take Down Warriors as Antetokounmpo Steals the Show in Minion Costume
- How Blue Jays' Vladimir Guerrero Jr. already joined Barry Bonds in World Series history